tiprankstipranks
Biosyent Inc (TSE:RX)
:RX
Canadian Market

Biosyent (RX) Income Statement

Compare
44 Followers

Biosyent Income Statement

Last quarter (Q3 2024), Biosyent's total revenue was C$9.56M, an increase of 7.72% from the same quarter last year. In Q3, Biosyent's net income was C$2.31M. See Biosyent’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ 31.59MC$ 27.93MC$ 28.62MC$ 22.33MC$ 21.42M
Gross Profit
C$ 25.60MC$ 22.86MC$ 22.64MC$ 17.42MC$ 16.65M
Operating Expenses
C$ 18.13MC$ 15.95MC$ 14.39MC$ 12.30MC$ 11.26M
Depreciation and Amortization
C$ 455.34KC$ 451.00KC$ 457.11KC$ 510.42KC$ 291.73K
EBITDA
C$ 9.06MC$ 7.96MC$ 8.92MC$ 5.84MC$ 6.19M
Operating Income
C$ 7.47MC$ 6.98MC$ 8.18MC$ 5.03MC$ 5.39M
Other Income/Expenses
C$ 1.06MC$ 448.65KC$ 195.22KC$ 206.96KC$ 482.39K
Pretax Income
C$ 8.53MC$ 7.43MC$ 8.38MC$ 5.24MC$ 5.87M
Net Income
C$ 6.46MC$ 5.46MC$ 6.28MC$ 3.80MC$ 4.37M
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ 0.54C$ 0.44C$ 0.50C$ 0.29C$ 0.31
Diluted EPS
C$ 0.53C$ 0.44C$ 0.49C$ 0.29C$ 0.31
Weighted Average Shares Outstanding
11.95M 12.30M 12.69M 13.00M 13.95M
Weighted Average Shares Outstanding (Diluted)
12.17M 12.54M 12.87M 13.09M 13.95M
Currency in CAD

Biosyent Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis